Life Science Leader Blogs

  1. Can A Better Patient Experience Lead To A Better Patient Outcome?
    9/8/2016

    My colleague, Ed Miseta, chief editor of Clinical Leader, recently asked, “Can Better Patient Experiences Lead To Better Medicines?” via an article he developed from an interview with Thomas Goetz, cofounder of Iodine, a digital health company. According to Miseta, Goetz is attempting to turn patient experiences into better medicines and is combining data and design to help patients locate the best treatments based on preferences, demographics, and experiences. But truthfully it wasn’t Goetz’s work that intrigued me (but still worth your reading about), but rather Miseta’s question.

  2. IO: Science Still Drives The Business
    9/2/2016

    How much science does a business person need to know? In this industry, the more the better. Without at least an excellent layperson’s understanding of the company’s scientific underpinnings, a life science executive will remain vulnerable to the greatest of all hazards in managing the business — today’s news.

  3. Rare Situation Results In Free Insights From GSK’s Global Vaccine President
    8/24/2016

    When conducting interviews my natural curiosity can result in a surplus of interesting content that often doesn’t fit with the overall theme of the final published article. When situations like these happen, I often proactively create articles for an online section called — From The Cutting Room Floor. One of my favorite examples of a cutting room floor article being able to provide valuable insight came from an interview with George Golumbeski, Ph.D., SVP of business development at Celgene. During the conversation I asked how a formally trained scientist moved into the area of business development. While his response of it being “one of the best business decisions he ever made” was fascinating, it wasn’t a fit with the overall M&A theme of the July 2015 cover story — even as a sidebar.

  4. Will Cupping Be The Next Big Health Fad?
    8/11/2016

    As I sat down to write this blog, I was struck by the idea of why certain things become popular or gain legitimacy. Malcolm Gladwell describes the magic moment when an idea, trend, or social behavior crosses a threshold and begins to spread like wildfire in his book, The Tipping Point: How Little Things Can Make a Big Difference. Still, it seems rare to witness such an event actually taking place and even more difficult to predict these “moments.” For example, most of us probably never envisioned the 2014 A.L.S. ice bucket charity challenge becoming such a meteoric sensation. But while recently watching the Olympics, I think I did notice something that I anticipate will be the next big health craze — cupping.

  5. A Commentary On Biopharma’s Current Boston Fixation
    7/15/2016

    Merck recently announced its plans to lay off R&D workers at three East Coast sites; a move that will supposedly affect less than 10 percent of discovery, preclinical, and early development employees in Kenilworth and Rahway, N.J., and North Wales, PA.

  6. Living With Pricing
    7/2/2016

    Life Science Leader Launches a Search for Common Ground

  7. BIO Still Delivers
    6/22/2016

    If the BIO International Convention did nothing but assemble the 16,000 people who came to this year’s meeting in San Francisco, simply giving them a space to talk, that alone would be a great achievement.

  8. Is BIO’s Annual Meeting Too Big?
    6/13/2016

    As a past BIO educational planning committee co-chair, I am well aware of the amount of effort that goes into the successful planning one of our industry’s biggest gatherings — BIO International’s Annual Convention. Typically drawing more than 15,000 attendees from nearly every U.S. state and over 65 countries, this year’s event took place June 6 – 9 at the Moscone Center in San Francisco. And while I have always been a big fan of BIO, this year’s event made me wonder: Is BIO too big to be effective? After all, the event boasts having 7 product zones, 18 educational tracks, 6 super sessions, 2 keynotes, and 3 fireside chats. That doesn’t even include the roughly 4,000 companies represented at the event, 1,800 of which typically exhibit.

  9. Who Will Move Biopharma Beyond The Cutting Edge At BIO 2016?
    5/31/2016

    When you think of companies that revolutionized the way business is done, it is important to consider the attributes of their founders. Often they had gained life experience from working in businesses best be described as tangential to those they eventually disrupted. As a result, these “outsiders” not only brought a different perspective toward tackling problems in these industries, their wisdom to do things differently than in the past resulted in ideas that forever changed the world. For example, Malcom McLean was the founder of a trucking company.

  10. How HBA’s Woman Of The Year Became A Successful Leader
    5/17/2016

    As Jennifer Cook strides across the stage at the Hilton New York Midtown, it is difficult to envision the 2016 Healthcare Businesswomen’s Association’s (HBA) Woman of the Year (WOTY) as being anything but extremely confident. But during her acceptance speech, the Roche executive paints a very different portrait of her early self. “When I was growing up, I was shy, very studious, and quite frankly, insecure,” she admits. “I’ve always had a strong regard for authority and was very willing to follow instructions, trusting that people in charge must know best.”